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METHODOLOGY
Individual level covariate adjusted 
conditional autoregressive (indiCAR) model 
for disease mapping
Md. Hamidul Huque1,2* , Craig Anderson1,2, Richard Walton3 and Louise Ryan1,2
Abstract 
Background: Mapping disease rates over a region provides a visual illustration of underlying geographical variation 
of the disease and can be useful to generate new hypotheses on the disease aetiology. However, methods to fit the 
popular and widely used conditional autoregressive (CAR) models for disease mapping are not feasible in many appli-
cations due to memory constraints, particularly when the sample size is large. We propose a new algorithm to fit a 
CAR model that can accommodate both individual and group level covariates while adjusting for spatial correlation in 
the disease rates, termed indiCAR. Our method scales well and works in very large datasets where other methods fail.
Results: We evaluate the performance of the indiCAR method through simulation studies. Our simulation results 
indicate that the indiCAR provides reliable estimates of all the regression and random effect parameters. We also 
apply indiCAR to the analysis of data on neutropenia admissions in New South Wales (NSW), Australia. Our analyses 
reveal that lower rates of neutropenia admissions are significantly associated with individual level predictors including 
higher age, male gender, residence in an outer regional area and a group level predictor of social disadvantage, the 
socio-economic index for areas. A large value for the spatial dependence parameter is estimated after adjusting for 
individual and area level covariates. This suggests the presence of important variation in the management of cancer 
patients across NSW.
Conclusions: Incorporating individual covariate data in disease mapping studies improves the estimation of fixed 
and random effect parameters by utilizing information from multiple sources. Health registries routinely collect indi-
vidual and area level information and thus could benefit by using indiCAR for mapping disease rates. Moreover, the 
natural applicability of indiCAR in a distributed computing framework enhances its application in the Big Data domain 
with a large number of individual/group level covariates. CI NSW Study Reference Number: 2012/07/410. Dated: July 
2012.
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Background
The risks of many diseases and health outcomes may vary 
across geographical locations because of locally varying 
distributions of socioeconomic, behavioural and envi-
ronmental risk factors [1]. These spatially correlated risk 
factors can have important implications for the observed 
disease rates in small areas. Mapping disease rates over 
a region offers a visual illustration of geographical vari-
ation. These maps are particularly useful for generating 
new hypotheses through identifying apparently high risk 
areas or disease clusters  [2]. However, producing such 
maps is complicated by the fact that raw incidence rates 
are often unstable due to small incidence counts, spatial 
correlation among rates and also due to the variation in 
individual patient characteristics [3–5].
Poisson mixed models with conditional autoregres-
sive random effects are commonly used for assess-
ing the relationship between a rare disease outcome 
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and risk factors in the presence of geographical vari-
ation  [6]. These models can adjust for region specific 
spatial random effects for correlated disease rates and 
both individual- and region-specific covariates. How-
ever, the fitting of such models is subject to high com-
putational burden, particularly when the sample size 
is large and when the number of individual and group 
level covariates are large. To alleviate such problems, 
investigators often adjust for the age and sex distribu-
tion of the underlying population through calculation 
of an offset in the model [7]. Therefore, the effect of 
age and sex on disease risk can not be estimated from 
these models. Moreover, such an approach ignores a 
large number of potential individual level covariates 
that may be related to the underlying disease process 
and readily available in health registries.
Health registries routinely collect geo-coded infor-
mation relating to the patient’s residence at diagnosis, 
their socio-demographic status and their clinical char-
acteristics. In addition, information on locally vary-
ing socioeconomic, behavioral and environmental risk 
factors for each area under study can also be obtained 
from other data sources. For example, in Australia, 
New South Wales (NSW) cancer registries collect 
cancer treatment and outcome information for each 
patient diagnosed with cancer, along with their socio-
demographic characteristics. Additionally, a socio-
economic index for areas (SEIFA) and an area specific 
index for remoteness (ARIA) of each patient’s resi-
dence can be obtained from the Census Bureau. Com-
bining these individual and area level characteristics 
in mapping studies can help researchers and policy 
makers to understand the relative contribution of both 
individual and group level covariates to the observed 
cancer rates. In addition, combining such data can also 
reduce ecological bias, which occurs when the group 
level exposure–disease relationship does not reflect 
the individual level relationship. A reduction in this 
bias leads to improved inference about both our group 
and individual level covariates  [8, 9]. In this paper we 
propose a novel approach that enables the study of 
individual level risk factors in mapping studies.
The aim of our current research is to make use of rou-
tinely collected administrative cancer treatment and 
outcome data to explore the possible geographical varia-
tion in the rate of neutropenia admissions corresponding 
to all cancer types across NSW. Neutropenia is a blood 
disorder with an abnormally low number of neutrophil 
granulocytes (a type of white blood cell in the blood), 
often associated with fever. It is a life threatening com-
plication of cancer chemotherapy and a major cause 
of morbidity and associated healthcare resource costs. 
Furthermore, neutropenia results in compromised effi-
cacy due to delays and dose reductions in chemotherapy 
[10].
NSW is the most populated state in Australia with a 
population of approximately 7.6 million people. Geo-
graphical variations in neutropenia admissions are of 
particular interest because of the uneven geographi-
cal concentration of the population within the state. As 
a result of this uneven population density, the level of 
access to health care services is not uniform across the 
whole region [11]. Moreover, neutropenia incidence 
might also depend on patient age and cancer type, as 
treatment modalities often vary across different types 
of cancer and age groups. Therefore, appropriate analy-
sis of geographical variation of neutropenia admissions 
requires adjustment for both the patient’s demographic 
characteristics and covariates reflecting the patient’s 
geographic location of residence. In our current applica-
tion, we explore whether there is any spatial variation in 
the rates of neutropenia admissions after adjusting for 
patients’ individual and clinical characteristics.
In our proposed method, hereafter known as indiCAR, 
we incorporate individual level covariate information in a 
two step iterative procedure following an initialization step. 
At the initialization step, individual level outcome data 
were fitted against individual level covariates with a Poisson 
generalized linear model (GLM), ignoring random effects 
and group level covariates. Then, at the first step, the indi-
vidual level outcome data were aggregated at the area level 
and fitted via a Poisson generalized linear mixed model 
(GLMM) against area level covariates including a condi-
tional autoregressive spatial random effect, and an offset 
calculated based on individual covariate contributions. At 
the second step, the individual level outcome data is fitted 
via a Poisson GLM with individual level covariates and a 
second offset calculated based on the contribution of area 
specific covariates and random effects obtained from the 
previous step. Steps 1 and 2 are repeated until convergence.
We evaluate the performance of our indiCAR method 
through simulation studies and also compare indiCAR 
to the traditional method of age-sex standardisation [7]. 
Our simulation results show that the proposed indiCAR 
approach is able to correctly estimate coefficients asso-
ciated with both individual and group-level covariates. 
Simulation studies also reveal that our approach is faster 
than existing approaches such as hlmer with CAR for 
fitting spatial random effects when the number of indi-
viduals within a group is low, and works for large sample 
sizes where these other methods fail. We illustrate our 
proposed indiCAR method using data on neutropenia 
admissions from the NSW Cancer Institute and conclude 
with some practical guidelines.
Page 3 of 13Huque et al. Int J Health Geogr  (2016) 15:25 
Methods
Data
NSW cancer registries were used to identify patients 
diagnosed with cancer, associated treatment procedures 
and co-morbidities. Specifically, we used data from the 
NSW Central Cancer Registry (CCR) linked to NSW 
Admitted Patient Data Collection (APDC). Detailed 
descriptions of the data items can be obtained from the 
Centre for Health Record Linkage (CHeReL http://www.
cherel.org.au/master-linkage-key). Data were checked for 
consistency across data sources and linked by assigning 
a unique project person number (PPN) to each patient. 
Our study population comprises all cancer patients that 
were diagnosed with cancer and were hospitalized during 
the period between 2001 and 2009.
Demographic variables including age at diagnosis, gen-
der, residence at diagnosis, postal area of residence, and 
the ARIA were obtained from the CCR database. The 
ARIA variable was recorded at individual level rather 
than postal area level because the ARIA index varies 
within postal areas. The SEIFA (an index of social disad-
vantage) and the geo-coded shape files for mapping cor-
responding to 2006 census postal areas were obtained 
from the Australian Bureau of Statistics (ABS). Individual 
level clinical characteristics such as type of cancer were 
also obtained from the CCR. The diagnosis of neutro-
penia admissions and co-morbidity were obtained using 
data from the APDC. The ICD-10-AM (International 
Statistical Classification of Disease and Related Health 
problem, 10th revision, Australian modification) code 
D70 (agranulocytosis) was used to identify admissions 
with possible neutropenia.
The model
Suppose the total area under study is divided into M con-
tiguous regions and the number of neutropenia admis-
sions for the ith (i = 1, 2, . . . , nj) individual in the jth 
(j = 1, 2, . . . ,M) region is denoted by {yij}. Let Y  be a 
vector with elements {yij} that represents the number of 
neutropenia admissions for all individuals in the study 
regions of interest. Similarly, let X = (X1,X2, . . . ,Xp) 
and U = (U1,U2, . . . ,Uq) represent individual and area 
level covariate matrices with dimensions n× p and 
M × q, respectively, where n is the total sample size i.e., 
n =
∑M
j=1 nj. We define a replication matrix, Z of dimen-
sion n×M to map group level covariates and random 
effects to the individual level as
Z =


1n1×1 0n1×1 · · · 0n1×1
0n2×1 1n2×1 · · · 0n2×1
...
...
. . .
...
0nM×1 0nM×1 · · · 1nM×1

.
Under the above specifications, conditional on the area 
specific random effect vector, b, the number of neutrope-
nia admissions for each cancer patient is assumed to be a 
Poisson random variable with mean µ, given by
where β and γ are the vectors of regression coeffi-
cients associated with the individual level and group 
level covariates, respectively. Of course, it is possible to 
express model (1) by replicating group level covariate 
data to the individual level and including them within 
the design matrix, X . However, such a formulation often 
results in high computational burden and a large amount 
of storage memory allocation. Instead, formulation (1) 
helps to fit individual and group level data separately in a 
distributed computing framework as will be shown at the 
end of the current section.
Many different choices for modelling the random 
effect, b are available in the mapping literature (see [6], 
for a recent review). Among these, the method of Leroux 
et  al.  [7] is appealing because it allows varying weights 
between spatially structured and unstructured varia-
tion  [7]. Within this framework, the random effect vec-
tor, b has a multivariate normal distribution with mean 0 
and a covariance matrix, D delivered through its Moore-
Penrose generalized inverse, D− = σ−2{(1− λ)I + λR} , 
where I is the identity matrix, R is the intrinsic auto 
regression matrix reflecting the neighbourhood struc-
ture. Typically, neighbours are those areas which share a 
common boundary, but distance based neighbourhood 
structures can also be used [12]. Underlying the Ler-
oux et al. [7] approach is the specification of the general-
ized inverse of the covariance matrix D. This formulation 
therefore avoids inverting the covariance matrix D. Alter-
natively, one can restrict λ to the range (0, 1), thus ensur-
ing that D is invertible. The typical element of R is given 
by
where mj is the number of neighbours of region j, and 
I{j ∼ j′} is an indicator function that takes value 1 if 
regions j and j′ are neighbours and 0 otherwise. The 
parameters characterising the random effect distribu-
tion, θ = (σ 2 > 0,λ ∈ [0, 1]) quantify overdispersion 
and spatial dependence respectively. A larger value of 
λ ∈ [0, 1] indicates a higher degree of spatial correlation 
among proximal areal units. This specification results 
in two extreme cases: (1) completely independent ran-
dom effects when λ = 0 and (2) the intrinsic autoregres-
sive model when λ = 1  [4]. In cases where 0 < λ < 1, a 
weighted combination of these extreme cases is assumed.
(1)ln(µ) = Xβ + ZUγ + Zb.
Rjj′ =
{
mj , j = j
′
−I
{
j ∼ j′
}
j �= j′,
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Since the random effects, b are unobserved, inference 
about β, γ and θ can be made by integrating out the distri-
bution of the random effects, b. The corresponding inte-
grated quasi-likelihood function is equal to (see equation 
(2) of Breslow and Clayton [13])
where d(Y ,µ) refers to the deviance residual associated 
with observation Y.
The maximum likelihood estimates of β, γ and θ are 
simply those values which maximize the above quasi-
likelihood. However, no simple closed form expression 
exists for the integral. Instead, Breslow and Clayton [13] 
proposed the penalized quasi-likelihood (PQL) approach 
for parameter estimation and inference. The PQL uses 
Laplace’s method for integral approximation and jointly 
maximizes the following quasi-likelihood function to 
obtain estimates for β, γ and b(θ) (see equation (6) of 
Breslow and Clayton [13])
 Under the above specification the approximate log-likeli-
hood can be expressed as
Differentiating (3) with respect to β, γ and b using vec-
tor matrix calculus [14], we obtain the following score 
equations
and
Iterative re-weighted least squares (IRLS) can be applied 
to solve the above equations for β, γ and b. However, high 
computational costs and memory space constraints often 
make it difficult to apply these iterative procedures to 
data sets with a very large number of cases. An alterna-
tive computational strategy is the use of the Gauss–Sei-
del algorithm. In this method, at each iteration, one of 
the parameters is estimated while keeping other param-
eters fixed at current values. The advantage of such 
|D|−
1
2
�
exp

−1
2
M�
j=1
nj�
i=1
dij(Yij ,µij)−
1
2
bTD−b

db,
(2)−
1
2
M∑
j=1
nj∑
i=1
dij(Yij ,µij)−
1
2
bTD−b.
(3)
const + Y T(Xβ + ZUγ + Zb)
− 1T exp(Xβ + ZUγ + Zb)−
1
2
bTD−b.
(4)
{
Y − exp(Xβ + ZUγ + Zb)
}T
X = 0,
(5)
{
Y − exp(Xβ + ZUγ + Zb)
}T
ZU = 0,
(6)
{
Y − exp(Xβ + ZUγ + Zb)
}T
Z = bTD−.
an approach is that substantial simplifications can be 
obtained at each step. Using this approach, we first ini-
tialize β and then obtain updated estimates for γ and b in 
the following two step procedure:
Step 0   Set the coefficients corresponding to area level 
covariates, γ and random effects, b to 0 in Eq.  (4). Then 
we have
This equation is the estimating equation for a Poisson 
generalized linear model [14] and thus can be fitted using 
the existing glm function in the R statistical comput-
ing environment [15]. This gives initial estimates of the 
regression coefficient β associated with individual level 
covariates.
Step 1   Substitute the current estimated individual 
level coefficients, β̂ in Eqs. (5) and (6) and with some sim-
ple algebra, we have
and,
where Y Tc = Y TZ is a vector of aggregated disease counts 
of length M at the group level and O1 = log{ZT exp(X β̂)} 
is a vector of offset with length M.
The above two equations are well known PQL estimat-
ing equations for the Poisson mixed model  [13]. Since, 
the outcome Y c, offset O1, covariate U  and random 
effects b are all measured at the group level, estimates 
of parameters for the group level coefficient γ̂  and ran-
dom effects b can be estimated using the PQL method [7, 
13] with only group level data. The detailed procedure is 
described in Appendix 1.
Step 2   Now substitute the estimated area-specific 
regression coefficient, γ̂  and random effect parameter, b̂ 
estimated at step 1 in (4). Then we have
where O2 = Z(U γ̂ + b̂) is an offset vector of length n. 
Under the above specification, the individual level coef-
ficients estimate β̂ can then be updated using ordinary 
Poisson regression with individual level data.
Steps 1 and 2 are then repeated until the algorithm 
converges. Estimates obtained by this iterative procedure 
{
Y − exp(X β̂)
}T
X = 0.
{
Y c − exp(O1 +Uγ + b)
}T
U = 0
{
Y c − exp(O1 +Uγ + b)
}T
= bTD−,
{
Y − exp(Xβ +O2)
}T
X = 0,
Page 5 of 13Huque et al. Int J Health Geogr  (2016) 15:25 
will be the same, aside from rounding error as the solu-
tion obtained by a standard IRLS algorithm.
Estimation of standard error
The approximate standard error estimates for γ̂  and β̂ 
in steps 1 and 2 assume fixed β and fixed γ, respectively. 
Therefore, we re-calculated the standard error of these 
regression coefficients by adjusting the variability of the 
estimated β̂ and γ̂ . This can be done via the IRLS esti-
mation of score equations (4–6). The IRLS estimation 
requires us to define a working dependent variable and 
a weight matrix that are updated at each iteration and 
solved via Fisher scoring [13].
Let the GLM adjusted dependent variable, Y pseudo be
where W  is a n× n diagonal matrix with diagonal ele-
ments µ. Harville [16] and Robinson [17] showed that the 
Fisher scoring corresponding to the score equations (4–
6) and GLM dependent variable as in (7), is identical to 
the normal equation of the best linear unbiased predic-
tors (BLUPs) of β, γ and θ corresponding to the following 
linear mixed model
where the pseudo-error ǫpseudo ∼ N (0,W−1). Following 
[17], the estimated regression coefficients for the fixed 
effects, (β , γ ) and BLUP estimate for the random effect b 
can be obtained as
where C = [X |ZU ] and V = ZDZT +W−1, the variance 
of pseudo-response Y pseudo. Thus, the variance–covari-
ance matrix for the fixed effect (β̂ , γ̂ ) can be estimated by
Note that Eq. (9) suggests that estimates of the regression 
coefficients and variance components can be obtained 
using the Leroux et al. [7] model with appropriate speci-
fication of the design matrix (Z) associated with spatial 
random effect (1). Indeed, a back-fitting approach such 
as indiCAR will be effective in situations where memory 
constraints may prohibit fitting a single model consist-
ing of all individual and group level covariates. A useful 
feature of our indiCAR method is that we can calculate 
the above standard error in a distributed computing 
framework. This is because V−1 can be expressed as 
W −WZD(I + ZTWZD)−1ZTW   [18]. Therefore, the 
above variance–covariance matrix can be written as
(7)Y pseudo = Xβ + ZUγ + Zb +W
−1(Y − µ)
(8)Y pseudo = Xβ + ZUγ + Zb + ǫpseudo,
(9)
(
β̂ , γ̂
)
=
(
CTV−1C
)−1(
CTV−1Y pseudo
)
b̂ = DZTV−1
{
Y − X β̂ − ZU γ̂
}
(10)Q =
(
CTV−1C
)−1
.
where a11 = XTWX − XTWZD(I + ZTWZD)−1 × ZT 
WX, a12 = XTWZU − XTWZD(I + ZTWZD)−1 × ZT 
WZU  , a21 = aT12, a22 = UTZTWZU −UTZTWZD× 
(I + ZTWZD)−1ZTWZU  . Among the various compo-
nents of the above variance-covariance matrix, XTWX 
and XTWZ are the only terms involving individual level 
data, and the rest of the terms involve a lower dimension 
corresponding to the group level data. These compo-
nents are therefore straightforward to calculate. Hence, 
upon convergence, calculation of the variance–covari-
ance matrix is also carried out in a distributed computing 
framework for individual and group-level data separately.
The covariance matrix for b̂ was obtained from the 
Fisher information matrix from step 2 in the usual way, 
assuming that parameters for the individual and area 
specific covariates are fixed. Of course there is addi-
tional variability due to the fact that the individual and 
area specific covariates parameters are estimated. How-
ever, following Breslow and Clayton  [13] we ignore this 
additional variability when making inference about the 
parameters which characterise the random effect distri-
bution, θ̂ . The detailed procedure is given in Appendix 1.
In the next section we describe a simulation study to 
evaluate the performance of our method.
Simulation studies
To evaluate our proposed method we design a simulation 
study involving 400 regions in a 20× 20 square lattice grid 
with varying sample sizes. Specifically, we consider cases 
with (i) 10–1000 and (2) 10–50 subjects in each area. We 
declare two regions to be neighbours if they share a com-
mon border. The random effects are generated following a 
multivariate normal distribution with mean 0 and covari-
ance matrix D = [σ−2{(1− λ)I + λR}]−1. The value of σ 
is set to 0.4 and five different values of spatial dependence 
parameters, λ = {0, 0.25, 0.50, 0.75, 0.99} are considered 
in order to represent different strengths of spatial corre-
lation. We then generate three individual level covariates 
(one binary, one categorical and one continuous) and one 
group level covariate. The binary covariate represents the 
distribution of sex in the area and is generated following a 
Bernoulli random variable with probability ranging from 
0.45 to 0.55 across groups. The categorical variable with 
six categories is generated to represent the age distribu-
tion of the neutropenia admissions data with prespecified 
probabilities (similar to the neutropenia admissions data). 
The continuous individual level variable is generated as 
Uniform (0.2, 1). The group level covariate is generated 
from a standard normal distribution. The outcome vari-
able is then generated using model (1). The full list of the 
Q =
(
a11 a12
a21 a22
)−1
,
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parameters used to generate data is given in Table 1. The 
binary and the categorical individual level variables help 
us to compare our simulation results for the indiCAR with 
the age-sex adjusted Leroux et al. [7] approach.
Results and discussion
In this section we discuss our results obtained from 
the simulation study and present an application to the 
neutropenia admissions data. We compare the results 
obtained by indiCAR to those from the existing Leroux 
et al.  [7] method. When applying indiCAR to the simu-
lated data, we adjust for all individual and areal covari-
ates. However, in the existing Leroux et al. [7] method we 
were only able to incorporate the binary and categorical 
variable by calculating offsets based on direct standardi-
zation of these covariates.
Simulation results
Table  1 displays the average estimated regression coef-
ficients along with their estimated standard errors for 
the indiCAR and Leroux et  al.  [7] methods based on 
1000 simulation runs based on simulation scenario (1). 
We estimated two different standard errors of estimated 
regression coefficients: namely, (1) empirical stand-
ard errors i.e., taking the standard deviation of the 1000 
simulated regression coefficient estimates, (2) average of 
model based standard errors. The first column of Table 1 
specifies the spatial dependence parameter used in that 
particular simulation. The next eight columns list the 
estimated regression coefficients for the individual level 
covariates using the indiCAR method. The 10th, 11th 
and 12th columns list the estimated group level regres-
sion coefficients, the estimated overdispersion param-
eters and estimated spatial dependence parameters for 
the spatial random effect using the indiCAR method. 
The last three columns list the estimated regression coef-
ficients for the group specific covariate and estimated 
overdispersion and spatial dependence parameters using 
the Leroux et al. [7] method. The Leroux et al. [7] method 
adjusts only for the binary and categorical variables.
As expected, the indiCAR method provides reli-
able estimates of the individual level and region specific 
regression parameters and the parameters in the spatial 
random effect. Although the Leroux et  al.  [7] method 
provides similar reliable estimates of the true region-
specific regression parameters, the random effect param-
eters are slightly biased.
To evaluate the performance of the proposed method 
under small sample settings, we also conducted simula-
tions with only 10–50 subjects per region as outlined in 
simulation scenario (2).These results are given in Table 2. 
As indicated in the table, the proposed method performs 
very well in this setting, providing reliable estimates of all 
the parameters. In contrast, the Leroux et al. [7] method 
provides slightly less efficient estimates of the spatial 
dependence parameters.
Table 1 Simulation results for estimated regression coefficients following indiCAR and Leroux et al. [7] where each area 
consists of a random number of subjects between 10 and 1000
True 
value
indiCAR Leroux et al. [7] 
approach
 β0 −0.20  β1 −2.50  β2 0.70  β32 −2.00  β33 −1.50  β34 0.20  β35 0.50  β36 0.80  γ 0.20  σ 0.40  λ  γ 0.20  σ 0.40  λ 
 λ Estimated coefficient
 0.00 −0.178 −2.500 0.700 −1.997 −1.500 0.201 0.501 0.800 0.199 0.396 0.019 0.198 0.442 0.069
 0.25 −0.174 −2.499 0.699 −1.997 −1.498 0.200 0.501 0.801 0.198 0.395 0.251 0.198 0.421 0.304
 0.50 −0.162 −2.500 0.700 −2.001 −1.501 0.200 0.500 0.801 0.198 0.396 0.503 0.198 0.413 0.523
 0.75 −0.152 −2.501 0.701 −2.005 −1.499 0.201 0.500 0.800 0.198 0.394 0.736 0.198 0.407 0.722
 0.99 −0.144 −2.499 0.700 −2.000 −1.500 0.200 0.499 0.799 0.199 0.396 0.958 0.199 0.412 0.950
Empirical standard error
 0.00 0.033 0.016 0.012 0.059 0.039 0.025 0.026 0.026 0.021 0.030 0.028 0.022 0.035 0.056
 0.25 0.037 0.016 0.011 0.060 0.039 0.027 0.026 0.027 0.017 0.033 0.101 0.017 0.035 0.106
 0.50 0.042 0.016 0.012 0.058 0.040 0.027 0.027 0.026 0.016 0.029 0.130 0.016 0.028 0.120
 0.75 0.054 0.016 0.012 0.061 0.039 0.028 0.027 0.028 0.013 0.025 0.114 0.014 0.025 0.106
 0.99 0.209 0.017 0.012 0.064 0.038 0.027 0.027 0.027 0.012 0.020 0.037 0.013 0.020 0.043
Average of the simulated standard error
 0.00 0.034 0.016 0.012 0.061 0.039 0.027 0.027 0.027 0.021 0.016 0.026 0.022 0.018 0.031
 0.25 0.036 0.016 0.012 0.061 0.039 0.028 0.027 0.027 0.017 0.017 0.053 0.018 0.018 0.058
 0.50 0.041 0.016 0.012 0.062 0.039 0.028 0.027 0.027 0.015 0.018 0.079 0.015 0.018 0.080
 0.75 0.028 0.016 0.012 0.062 0.039 0.028 0.027 0.027 0.014 0.019 0.086 0.014 0.019 0.086
 0.99 0.130 0.016 0.012 0.062 0.040 0.028 0.027 0.028 0.013 0.019 0.034 0.013 0.020 0.038
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Following reviewer suggestions, we also compared 
the indiCAR method with three other methods; a group 
specific random intercept model (1) using the lme4 
[19] and (2) using the hglm [20] packages in R and (3) 
a CAR model implemented using the hlmer function in 
the hglm R package. The three methods were compared 
in terms of both approximate conditional AIC [21] and 
computation time. The results are given in Tables 3 and 
4. In Table 3, the data were generated with λ = 0, which 
means that a random intercept only model is appropri-
ate. In Table 4, the data were generated with λ = 0.75, 
which means that a CAR component is necessary for 
an accurate model fit. Note that the conditional AIC 
values are approximate as these are calculated ignor-
ing the constant term in the log-likelihood. The hlmer 
approach is faster when block effects are represented 
by a random intercept, but is slower for a conditional 
autoregressive random effect specification. The fitting 
of hlmer with such a random effect specification is not 
even feasible for large sample sizes on our standard 
desktop computer due to large memory requirements. 
In addition, we note that another R package: sdep has 
similar feasibility issues when fitting a conditional 
autoregressive random effect model for large datasets 
[22]. Our proposed indiCAR method in general pro-
vides lower conditional AIC compared to other models 
considered here and is faster than the hlmer approach 
when using a CAR random effect specification, as we 
do in our application. 
Application to the neutropenia data
We applied our methodology to the data on neutropenia 
admissions. One of the key objectives of this analysis is to 
assess the geographical variation of neutropenia admis-
sion rates and its association with area level measures 
of socioeconomic status. Data also includes patient age, 
gender, year of diagnosis, ARIA, cancer type at diagnosis, 
number of major comorbidities and geographic location 
reported via postcode of residence.
Table  5 shows the descriptive statistics for cancer 
patients treated between years 2001 and 2009 in New 
South Wales, Australia. The proportion of neutrope-
nia admissions decreases gradually with increasing age 
(9.2 % for 20–30  years of age to 1.7  % for 80+  years of 
age). Overall, the rates are similar (≈5  %) across the 
years 2001–2008 but are considerably lower (3.0  %) in 
the year 2009. This is likely due to the fact that the data 
are date limited for those patients diagnosed with cancer 
and treated with chemotherapy in 2009. Cancer treat-
ment often has a long duration, and subsequent neutro-
penia admissions may have happened beyond the study 
period. The proportion of neutropenia is highest (4.9 %) 
in the major cities followed by inner regional Australia 
(3.9  %). Among the various types of cancer, the highest 
proportion of neutropenia admissions are observed for 
Table 2 Simulation results for estimated regression coefficients following indiCAR and Leroux et al. [7] where each area 
consists of a random number of subjects between 10 and 50
True 
value
indiCAR Leroux et al. [7] 
method
β0 −0.20 β1 −2.50 β2 0.70 β32 −2.00 β33 −1.50 β34 0.20 β35 0.50 β36 0.80 γ 0.20 σ 0.40 λ γ 0.20 σ 0.40 λ
λ Estimated coefficient
 0.00 −0.161 −2.495 0.697 −2.000 −1.481 0.210 0.509 0.811 0.197 0.380 0.043 0.189 0.444 0.059
 0.25 −0.175 −2.501 0.699 −2.020 −1.500 0.205 0.505 0.804 0.197 0.382 0.247 0.193 0.426 0.225
 0.50 −0.179 −2.500 0.701 −2.011 −1.509 0.199 0.501 0.802 0.199 0.380 0.462 0.195 0.430 0.396
 0.75 −0.177 −2.504 0.700 −2.038 −1.504 0.207 0.507 0.806 0.200 0.380 0.656 0.195 0.468 0.496
 0.99 −0.156 −2.498 0.700 −2.039 −1.505 0.204 0.505 0.802 0.199 0.402 0.929 0.197 0.510 0.856
Empirical standard error
 0.00 0.117 0.148 0.056 0.301 0.184 0.115 0.114 0.123 0.032 0.064 0.070 0.033 0.065 0.078
 0.25 0.086 0.050 0.038 0.200 0.120 0.086 0.081 0.083 0.026 0.047 0.154 0.027 0.053 0.147
 0.50 0.085 0.049 0.039 0.183 0.128 0.083 0.081 0.086 0.025 0.042 0.185 0.026 0.048 0.179
 0.75 0.125 0.071 0.051 0.260 0.163 0.118 0.110 0.115 0.027 0.051 0.200 0.029 0.056 0.217
 0.99 0.225 0.064 0.051 0.259 0.163 0.118 0.116 0.124 0.029 0.052 0.094 0.031 0.058 0.147
Average of the simulated standard error
 0.00 0.116 0.066 0.049 0.254 0.160 0.114 0.112 0.113 0.031 0.036 0.075 0.032 0.035 0.062
 0.25 0.092 0.051 0.038 0.197 0.125 0.088 0.086 0.087 0.025 0.033 0.114 0.027 0.032 0.096
 0.50 0.093 0.052 0.038 0.197 0.125 0.088 0.086 0.087 0.024 0.036 0.163 0.025 0.035 0.134
 0.75 0.122 0.067 0.049 0.261 0.163 0.115 0.113 0.114 0.028 0.051 0.191 0.029 0.047 0.163
 0.99 0.164 0.067 0.049 0.260 0.163 0.115 0.112 0.114 0.027 0.051 0.059 0.029 0.052 0.088
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haematological malignant cancer patients (25.0  %) fol-
lowed by lung (6.2 %) and breast cancer (5.3 %). The pro-
portion of neutropenia admissions are very similar across 
various SEIFA index categories.
Table 6 reports the multivariable analysis of neutrope-
nia admissions data using both the indiCAR approach 
and the Leroux et al. [7] method based on age-sex adjust-
ments. We calculate age-sex adjusted standardized inci-
dence ratios (SIR) by dividing the observed number of 
neutropenia admissions by the age-sex adjusted expected 
number of neutropenia admissions  [23]. Our results 
reveal significantly lower rates of neutropenia for patients 
with higher age, male gender, residence in an outer 
regional or remote area and higher socioeconomic sta-
tus. The estimated overdispersion (σ ) and spatial depend-
ence parameters (λ) with indiCAR are 0.204 and 0.992, 
respectively compared to 0.210 and 0.989 for the Leroux 
et al. [7] method. This means that both models identified 
a very strong spatial correlation in the neutropenia risk.
Although advanced age has been identified as a sig-
nificant predictor for neutropenia admissions in previ-
ous studies [24], we observed a lower risk of neutropenia 
admissions associated with increasing age. This might 
be due to the fact that the current guidelines for prophy-
lactic administration of colony stimulating factor (CSF) 
already account for age [25]. CSF is an effective treatment 
strategy to reduce neutropenia.
The relationship between average neutropenia rates 
and ARIA and SEIFA are in the opposite direction, 
which is counter intuitive as remote areas in NSW are 
mostly associated with disadvantaged SEIFA categories. 
However, the observed contrast in estimated regression 
Table 3 Comparison of estimated time and conditional AIC between indiCAR and other methods when data are gener-
ated without spatial random effect, λ = 0 
Sample 
per group
Total 
sample
Time to convergence (s) Conditional AIC
indiCAR glmer  
with random 
intercept
hlmer  
with random 
intercept
hlmer 
with CAR
indiCAR glmer  
with random 
intercept
hlmer  
with random 
intercept
hlmer 
with CAR
Data generated in 100 groups
 1:50 2373 0.73 1.98 0.43 2.36 1419.26 1492.26 1445.65 1445.87
 1:100 5056 2.09 5.26 0.55 2.93 3170.9 3225.28 3194.03 3193.98
 1:500 26,473 10.34 23.63 1.65 12.96 15,996.05 15,968.02 15,955.41 15,955.40
 1:1000 48,778 37.25 53.25 3.01 29.68 31,063.34 31,011.67 31,001.58 31,001.72
Data generated in 400 groups
 1:50 10,192 51.39 9.44 2.64 97.45 6027.28 6242.24 6097.72 6097.84
 1:100 19,843 73.31 33.13 11.39 244.02 12,017.28 12,185.15 12,037.20 12037.27
 1:500 98,870 140.74 71.96 38.91 Not feasible 59,061.39 58,929.01 58,879.30 Not feasible
 1:1000 205,952 207.84 214.51 149.96 Not feasible 121,733.50 121,533.80 121,510.20 Not feasible
Table 4 Comparison of estimated time and conditional AIC between indiCAR and other methods when data are gener-
ated with spatial random effect parameter, λ = 0.75 
Sample 
per group
Total 
sample
Time to convergence (s) Conditional AIC
indiCAR glmer  
with random 
intercept
hlmer  
with random 
intercept
hlmer 
with CAR
indiCAR glmer  
with random 
intercept
hlmer  
with random 
intercept
hlmer 
with CAR
Data generated in 100 groups
 1:50 2517 0.48 2.34 0.39 2.10 1748.78 1883.67 1881.69 1881.81
 1:100 4688 3.30 3.40 0.38 6.75 2821.61 2899.41 2897.73 2897.83
 1:500 26,519 4.23 23.71 1.92 15.52 15,865.50 15,943.65 15,943.58 15,943.55
 1:1000 52,911 188.19 61.84 3.62 Not feasible 32,632.45 32,669.39 32,669.18 Not feasible
Data generated in 400 groups
 1:50 10,118 51.55 14.81 2.65 138.33 5935.14 6323.31 6309.56 6309.44
 1:100 20,652 36.74 25.53 4.20 434.66 12,476.61 12,893.85 12,889.04 12,889.13
 1:500 103,267 85.75 73.45 22.31 Not feasible 60,233.22 60,533.49 60,533.24 Not feasible
 1:1000 205,739 113.65 236.95 46.23 Not feasible 120,212.20 120,423.70 120,423.00 Not feasible
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coefficients might be due to the differences in the health 
care practices. Patients in the remote areas are likely to be 
geographically distant to the treating medical oncologist 
Table 5 Descriptive analsis of neutropenia data
Variables Neutropenia n (%) Total
Age group (years)
 20–30 408 (9.2) 4418
 30–39 851 (7.7) 10,988
 40–49 1649 (6.2) 26,395
 50–59 2942 (5.6) 52,281
 60–69 3465 (4.8) 71,446
 70–79 2577 (3.7) 69,236
 80+ 769 (1.7) 44,859
Sex
 Female 6363 (5.0) 127,519
 Male 6298 (4.1) 152,104
Year of diagnosis
 2001 1343 (4.9) 27,356
 2002 1411 (5.0) 28,451
 2003 1503 (5.1) 29,560
 2004 1478 (4.8) 30,970
 2005 1596 (5.1) 31,533
 2006 1452 (4.6) 31,865
 2007 1453 (4.5) 32,603
 2008 1405 (4.2) 33,343
 2009 1020 (3.0) 33,942
ARIA
 Major cities 9199 (4.9) 189,322
 Inner regional Australia 2638 (3.9) 67,086
 Outer regional Australia 774 (3.6) 21,664
 Remote or very remote Australia 50 (3.2) 1551
Cancer type
 Breast cancer 2059 (5.3) 38,620
 Lung cancer 1401 (6.2) 22,744
 Colon and rectum cancer 1011 (3.0) 34,018
 Haematological malignancy 5134 (25.0) 20,518
 Other cancer 3056 (1.9) 163,723
No. of major comorbidities
 0 6072 (3.7) 163,645
 1 2228 (4.9) 45,817
 2 2315 (6.7) 34,670
 3 976 (5.7) 17,264
 4+ 1,070 (5.9) 18,227
SEIFA
 Most disadvantaged 1388 (4.6) 30,302
 2 1750 (4.1) 42,558
 3 3546 (4.5) 78,006
 4 2800 (4.6) 60,880
 Least disadvantaged 3177 (4.7) 67,877
Table 6 Comparison of  individual covariate adjusted con-
ditional autoregressive model (indiCAR) with  the Leroux 
et al. [7] method based on age-sex adjustments
Regression coefficients indiCAR Leroux et al.
Estimates SE Estimates SE
Intercept −2.781 0.110 – –
Age group (years)
 20–30 0.124 0.056 – –
 30–39 0.208 0.042 – –
 40–49 Ref.
 50–59 −0.119 0.031 – –
 60–69 −0.287 0.031 – –
 70–79 −0.712 0.033 – –
 80+ −1.586 0.045 – –
Sex
 Female Ref.
 Male −0.082 0.020 – –
Year of diagnosis
 2001 Ref.
 2002 0.018 0.038 – –
 2003 0.083 0.038 – –
 2004 0.021 0.038 – –
 2005 0.096 0.037 – –
 2006 0.036 0.038 – –
 2007 0.026 0.038 – –
 2008 −0.001 0.038 – –
 2009 −0.315 0.042 – –
ARIA
 Major cities Ref.
 Inner regional Australia −0.023 0.047 – –
 Outer regional Australia −0.147 0.068 – –
 Remote/very remote Australia −0.231 0.163 – –
Cancer type
 Breast cancer Ref. – – –
 Lung cancer 0.253 0.038 – –
 Colon and rectum cancer −0.434 0.040 – –
 Haematological malignancy 1.572 0.029 – –
 Other cancer −0.942 0.031 – –
No. of major comorbidities
 0 Ref. – –
 1 0.413 0.026 – –
 2 0.670 0.026 – –
 3 0.609 0.036 – –
 4+ 0.605 0.035 – –
SEIFA
 Most disadvantaged Ref.
 2 −0.083 0.044 −0.075 0.042
 3 −0.071 0.041 −0.068 0.038
 4 −0.125 0.047 −0.121 0.044
 Least disadvantaged −0.131 0.056 −0.129 0.052
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and hence managed by their primary care physicians. 
Consequently, these patients may be treated with lower 
doses of chemotherapy [26]. On the contrary, patients 
in the major cities might get intensive and aggressive 
chemotherapy, and are better managed due to availability 
of resources. Previous studies also indicate that remote-
ness has a great effect on the quality of cancer treatment 
[27] and that it affects treatment choices made by both 
patients and clinicians [28].
Figure  1 shows the SIR of neutropenia admissions in 
NSW. Six postal areas in NSW had an estimated SIR >3 
as shown in the map. Figure 2 shows a that neutropenia 
rates across NSW exhibit a very high spatial depend-
ence. The white region in the map of NSW is the Austral-
ian Capital Territory (ACT), which is a distinct territory 
not included in our dataset. Two other Australian states, 
Queensland (QLD) and Victoria (VIC) are located to the 
North-East and South-West of NSW, respectively. The 
strong spatial correlation after adjusting for individual 
and group specific covariates indicates that geographical 
variation of neutropenia might be due to differences in 
health care practices or access to care across NSW. Fur-
ther investigation at the hospital level would be needed 
in order to provide a comprehensive explanation of these 
findings. In some cases, a lower spatial random effect 
might be the result of low numbers of cancer patients 
being recruited in our study due to a border effect (i.e., 
getting admitted for neutropenia in other states: ACT, 
Victoria or Queensland) or due to areas being dominated 
by private cancer facilities.
Variation across clinical practices of neutropenia have 
been identified in Australia in a previous survey  [29]. 
The authors showed that the treatment approach for 
management of neutropenia varies across oncologists, 
hematologists and clinicians as well as different sectors of 
cancer care. Therefore, it might be interesting to explore 
whether the observed variation is due to variation across 
different hospitals (for example, metropolitan vs. non-
metropolitan hospitals) in NSW or across various health-
care providers. However, relevant data for such analysis 
are not collected in the registry and further exploration is 
beyond the scope of our present paper.
Our study was based on data linked from a state-based 
cancer registry and administrative data from the APDC. 
An advantage of such linked data is that it provides us 
with a large, population based sample. Registry based 
analysis is more comprehensive than that based on single 
centre studies, and provides more complete information 
than may be obtained from clinical trials where patient 
selection and loss to follow-up may impact validity and 
generalizability of study findings. However, it is impor-
tant to keep in mind that the resulting data quality may 
be inferior to that obtained from prospective studies.
We should note that in some cases, separate admis-
sions for the same individual may be correlated, and 
thus the Poisson assumptions for the number of admis-
sions may not be appropriate. In such cases, one could fit 
a subject specific random effect model at the individual 
level data rather than a generalized linear model [30]. In 
our application, we do not have such issues, because neu-
tropenia is a very rare event and we do not have any cases 
with recurrent neutropenia admissions. Therefore, it is 
Table 6 continued
Regression coefficients indiCAR Leroux et al.
Estimates SE Estimates SE
Variance parameter
 σ 0.204 0.022 0.210 0.022
 λ 0.992 0.012 0.989 0.015
Fig. 1 SIR of neutropenia admissions in NSW region following 
indiCAR
Fig. 2 Estimated spatial random effect across NSW using proposed 
indiCAR method
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suitable to use a Poisson approximation to the Binomial 
distribution for our dataset.
In our simulations, the estimation of the intercept 
β0 is biased. This is consistent with the observation of 
Hodges and Reich [31] that an intercept is poorly identi-
fied in the model with the presence of spatial random 
effect. The authors further argued that adding spatially 
correlated errors can attenuate the fixed effect estima-
tion. However, they only considered one observation 
per areal unit rather cases with replicated data such as 
that in our application. There may be other explanations 
for attenuations, for example, Huque et  al.  [32] argued 
that such attenuation is likely due to covariate measure-
ment error.
Despite various limitations, indiCAR is an useful addi-
tion to the existing methodology to explore clinical vari-
ation across geographical locations. One of the major 
advantages of our proposed method is the ability to 
analyze age as a continuous variable rather than group-
ing them using an arbitrary cut-off. The results of such 
an analysis are given in Appendix 2, though they are very 
similar to those using age groups. However, in many 
applications age grouping might induce residual con-
founding and result in spurious relationships between 
age and the outcome variable [33]. In our simulation 
study, we evaluate our proposed method for a continu-
ous area level covariate; however, interpretation of the 
SEIFA index is difficult as a continuous variable. There-
fore, to ease our interpretation we considered SEIFA as 
a categorical variable. We also conducted an analysis of 
neutropenia admissions data using continuous SEIFA 
index. The results are quite similar and indicate a signifi-
cant negative relationship between high SEIFA score and 
neutropenia admissions (result not shown in table).
Conclusions
In this paper we propose a novel method for incorpo-
rating individual level covariate information in disease 
mapping studies. As indicated in our simulation stud-
ies, our proposed method yields reliable estimates of 
individual and area level covariate effects. Our pro-
posed method also has potential for Big Data imple-
mentations due the natural applicability of indiCAR in 
a distributed computing framework. This could speed 
up the process and reduce large computational costs. 
Furthermore, indiCAR also provides a framework for 
fitting correlated Big Data using recently developed 
statistical methodology for uncorrelated Big Data [34, 
35]. Cancer registries routinely collect individual level 
cancer information and thus could benefit by using 
our proposed method to incorporate individual level 
information in the analysis and mapping of disease 
rates.
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Appendix 1: Implementation of PQL in step 1
The PQL estimation procedure is a iterative approach 
where at each step one must define a working dependent 
variable and a weight matrix which are then updated at 
each iteration and solved via Fisher scoring  [7, 13]. The 
detailed procedure has been illustrated elsewhere [7, 13].
The GLM adjusted dependent variable (Y c−pseudo) at 
group level is calculated as
where ηc = g(µc) = O1 +Uγ + b and O1 = log
{Z
T exp(X β̂)} is an offset vector with dimension M. 
The Poisson link (g(µc) = logµc) and variance function 
V (µc) = µc are used. The covariance matrix of Y c−pseudo 
is then approximated by
where Dˆ is the covariance matrix of the random effects, 
b, evaluated at the current estimate for the variance 
(11)Y c−pseudo = ηˆc + (Y c − µˆc)
dηˆc
dµˆc
,
(12)V̂c = Ŵc
−1
+ D̂,
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parameters and Wˆc is the M ×M diagonal matrix with 
diagonal elements µˆc. Updated estimates of the fixed 
effect vector γ and random effect vector b are then can be 
obtained from the solution of the following mixed model 
equations:
and
The updated estimates of the variance parameters, λ and 
σ are obtained by a Newton–Raphson iterative procedure 
as follows:
where S is the score vector and I is the expected informa-
tion matrix based on REML likelihood for Y c−pseudo. The 
expression for the elements of the score vector and infor-
mation matrix, letting θ = (θ1, θ2) = (σ , λ) are given by
and
where P = V−1c − V−1c U(UTV−1c U)−1UTV−1c . The deri-
vatives of Vc with respect to σ and λ are given below:
where Rλ = (1− λ)I + λR and R is the intrinsic autore-
gression matrix.
Repeated iteration of Eqs.  (11)–(15) allow us to obtain 
reliable estimates of the region specific fixed effect and ran-
dom effect parameters. Convergence is achieved when the 
change in parameter estimates are less than a prespecified 
tolerance level (<1e−3, in the simulation study reported). 
Approximate standard errors for λ and σ are obtained from 
the above information matrix in the usual way.
(13)γ̂ = (UTV̂c
−1
U)−1U V̂c
−1(
Y c−pseudo −O1
)
,
(14)b̂ = DˆV̂c
−1(
Y c−pseudo −O1 −U γ̂
)
.
(15)
(
σ̂
λ̂
)updated
=
(
σ̂
λ̂
)old
+ I−1S.
Si =
1
2
(
Y c−pseudo −U γ̂ −O1
)T
P
δVc
δθi
P
(
Y c−pseudo −U γ̂ −O1
)
−
1
2
tr
(
P
δVc
δθi
)
Ijk = −
1
2
tr
(
P
δVc
δθj
P
δVc
δθk
)
,
δVc
δσ
= 2σR−1λ
δVc
δλ
= σ 2R−1λ (R − I)R
−1
λ ,
Appendix 2
See Table 7.
Table 7 Application of  indiCAR with  age as  a continuous 
predictor
Regression coefficients Estimates SE
Intercept −1.493 0.047
Age −0.027 0.001
Sex
 Female Ref.
 Male −0.043 0.020
Year of diagnosis
 2001 Ref.
 2002 0.021 0.038
 2003 0.083 0.038
 2004 0.019 0.038
 2005 0.095 0.037
 2006 0.038 0.038
 2007 −0.022 0.038
 2008 −0.004 0.038
 2009 −0.315 0.042
ARIA
 Major cities Ref.
 Inner regional Australia −0.006 0.022
 Outer regional Australia −0.118 0.037
 Remote or very remote Australia −0.192 0.142
Cancer type
 Breast cancer Ref.
 Lung cancer 0.240 0.037
 Colon and rectum cancer −0.463 0.040
 Haematological malignancy 1.497 0.029
 Other cancer −0.986 0.031
No. of major comorbidities
 0 Ref.
 1 0.413 0.026
 2 0.682 0.026
 3 0.589 0.036
 4+ 0.594 0.035
SEIFA
 Most disadvantaged Ref.
 2 −0.089 0.043
 3 −0.078 0.038
 4 −0.134 0.045
 Least disadvantaged −0.144 0.053
Variance parameter
 σ 0.209 0.022
 λ 0.992 0.012
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